Levemir (tn)

Insulin detemir (produced by yeast through genetic recombination technology). 1 unit (U) is equivalent to 0.142 mg of anhydrous insulin detemir without salt.

There are a number of drugs known to affect glucose metabolism. Drugs that may reduce insulin requirements: oral hypoglycemic agents, monoamine oxidase inhibitors (MAOIs), non-selective beta-blockers, angiotensin converting enzyme (ACE) inhibitors, salicylates and alcohol. Drugs that may increase insulin requirements: thiazides, glucocorticoids, thyroid hormones and beta-sympathomimetics, growth hormone and danazol. Beta-blockers may mask the symptoms of hypoglycemia and delay recovery from hypoglycemia. Octreotide/lanreotide may both increase and decrease insulin requirements. Alcohol can exacerbate and prolong insulin-induced hypoglycemia. Contraindications Addition of other chemicals to this product may result in degradation of insulin detemir (e.g. drugs containing sulfhydryl groups or sulfites). This product is not for intravenous infusion.